Search

Displaying results 6171 - 6180 of 8697 in total
  1. Drug

    N-acetylmannosamine

    go.drugbank.com/drugs/DB12536
    Investigational

    N-acetylmannosamine is under investigation for the other of GNE Myopathy.

  2. Drug

    Spiradoline

    go.drugbank.com/drugs/DB12704
    Investigational

    Spiradoline has been investigated for the basic science of Bipolar Depression.

  3. Drug

    YMI024

    go.drugbank.com/drugs/DB32602
    Experimental

    YMI024 is a drug being investigated for inflammation-driven diseases.[L56081]

  4. Drug

    Lemuteporfin

    go.drugbank.com/drugs/DB04980
    Investigational

    It is intended for the treatment of beign prostatic hyperplasia.

  5. Drug

    Pudexacianinium

    go.drugbank.com/drugs/DB19161
    Investigational

    Pudexacianinium is under investigation in clinical trial NCT05754333 (A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery).

  6. Drug

    NPI 32101

    go.drugbank.com/drugs/DB05264
    Experimental

    This combination of pharmacological properties may have additional therapeutic uses beyond dermatology.

  7. Drug

    Sulfatide

    go.drugbank.com/drugs/DB04780
    Experimental

    Any of a class of cerebroside sulfuric esters, they are found largely in the medullated nerve fibers and may accumulate in metachromatic leukodystrophy.

  8. Drug

    Teglarinad chloride

    go.drugbank.com/drugs/DB05217
    Investigational

    GMX1777 is a water-soluble prodrug of the cyanoguanidine compound GMX1778 with potential antineoplastic activity. In vivo, apoptosis inducer GMX1777 is rapidly converted into GMX1778 through hydrolytic cleavage of a carbonate ester bond....

  9. Drug

    Vintafolide

    go.drugbank.com/drugs/DB05168
    Investigational

    Vintafolide is a folate-targeted chemotherapeutic conjugate (folate vitamin + vinca alkaloid) in clinical stage development as a treatment for folate-receptor positive cancers.

  10. Drug

    ATX-101

    go.drugbank.com/drugs/DB05780
    Investigational

    ATX-101 (medical), sodium deoxycholate for subcutaneous injection, is being evaluated as a treatment for the reduction of localized fat deposits. … ATX-101 demonstrates a relative selectivity for fat over other tissues.